Improved understanding of MARCH protein-mediated modulation of RLR signalling may facilitate development of new strategies for targeting the RLR pathway to achieve therapeutic control of viral infection and enhancement of the innate immune response. The gene discussed is CEP55; the disease is viral infectious disease.